Atteneder, C., Moayedifar, R., Koren, D., Fischer, G., Nackenhorst, M., Uyanik-Uenal, K., . . . Zuckermann, A. (2024). (195) - CD38-Antibody Daratumumab in Allosensitized Recipients for Heart Transplantation: Outcomes and 3-Years of Single-Centre Experience. Journal of Heart & Lung Transplantation, 43(4), S103. https://doi.org/10.1016/j.healun.2024.02.209
Chicago Style (17th ed.) CitationAtteneder, C., et al. "(195) - CD38-Antibody Daratumumab in Allosensitized Recipients for Heart Transplantation: Outcomes and 3-Years of Single-Centre Experience." Journal of Heart & Lung Transplantation 43, no. 4 (2024): S103. https://doi.org/10.1016/j.healun.2024.02.209.
MLA (9th ed.) CitationAtteneder, C., et al. "(195) - CD38-Antibody Daratumumab in Allosensitized Recipients for Heart Transplantation: Outcomes and 3-Years of Single-Centre Experience." Journal of Heart & Lung Transplantation, vol. 43, no. 4, 2024, p. S103, https://doi.org/10.1016/j.healun.2024.02.209.